Loxo Oncology Backtesting

Loxo Oncology Inc -- USA Stock  

USD 83.15  3.52  4.42%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Loxo Oncology Inc and determine expected loss or profit from investing in Loxo Oncology over given investment horizon. Please see also Loxo Oncology Hype Analysis, Loxo Oncology Correlation, Loxo Oncology Valuation, Loxo Oncology Volatility as well as analyze Loxo Oncology Alpha and Beta and Loxo Oncology Performance
Investment Horizon     30 Days    Login   to change

Loxo Oncology 'What if' Analysis

November 11, 2017
No Change 0.00  0.0%
In 31 days
December 11, 2017
If you would invest  0.00  in Loxo Oncology on November 11, 2017 and sell it all today you would earn a total of 0.00 from holding Loxo Oncology Inc or generate 0.0% return on investment in Loxo Oncology over 30 days. Loxo Oncology is related to or competes with NantKwest, Del Mar, VBI Vaccines, and Vascular Biogenics. Loxo Oncology Incs lead product candidate comprises LOXO101 an oral and selective inhibitor of tropomyosin receptor kina...

Loxo Oncology Upside/Downside Indicators


Loxo Oncology Market Premium Indicators

Loxo Oncology Inc lagged returns against current returns

 Current and Lagged Values 

Loxo Oncology regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Loxo Oncology Inc Backtested Returns

We consider Loxo Oncology not too volatile. Loxo Oncology Inc has Sharpe Ratio of 0.0107 which conveys that Loxo Oncology Inc had 0.0107% of return per unit of risk over the last 1 month. Our philosophy towards estimating volatility of a stock is to use all available market data together with company specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for Loxo Oncology which you can use to evaluate future volatility of the firm. Please verify Loxo Oncology Inc Downside Deviation of 3.12, Mean Deviation of 2.12 and Risk Adjusted Performance of 0.018 to check out if risk estimate we provide are consistent with the epected return of 0.0283%. Loxo Oncology has performance score of 0 on a scale of 0 to 100. The company secures Beta (Market Risk) of 2.1586 which conveys that as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Loxo Oncology will likely underperform.. Although it is extremely important to respect Loxo Oncology Inc price patterns, it is better to be realistic regarding the information on equity historical price patterns. The philosophy towards estimating future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By analyzing Loxo Oncology Inc technical indicators you can presently evaluate if the expected return of 0.0283% will be sustainable into the future. Loxo Oncology Inc right now secures a risk of 2.6362%. Please verify Loxo Oncology Inc Standard Deviation as well as the relationship between Value At Risk and Kurtosis to decide if Loxo Oncology Inc will be following its current price movements.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.59) 

Good reverse predictability

Loxo Oncology Inc has good reverse predictability. Overlapping area represents the amount of predictability between Loxo Oncology time series from November 11, 2017 to November 26, 2017 and November 26, 2017 to December 11, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Loxo Oncology Inc price movement. The serial correlation of -0.59 indicates that roughly 59.0% of current Loxo Oncology price fluctuation can be explain by its past prices. Given that Loxo Oncology Inc has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Loxo Oncology for similar time interval.
Correlation Coefficient -0.59
Spearman Rank Test -0.31
Price Variance 6.69
Lagged Price Variance 7.01

Loxo Oncology Lagged Returns

 Regressed Prices 

Loxo Oncology Performance vs DOW

The median price of Loxo Oncology for the period between Sat, Nov 11, 2017 and Mon, Dec 11, 2017 is 76.87 with a coefficient of variation of 3.75. The daily time series for the period is distributed with a sample standard deviation of 2.92, arithmetic mean of 77.72, and mean deviation of 2.36. The Stock received some media coverage during the period.
Price Growth (%)  
Sale by David Bonita of 8377 shares of Loxo Oncology11/20/2017